PDK4-介导的代谢重编程是新血管与年龄相关的黄斑退行症的潜在治疗点

Juhee Kim1,2, Yujin Jeon1,2, Jinyoung Son3,4

  • 1Department of Ophthalmology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea.

Cell death & disease
|August 9, 2024
PubMed
概括

向pyruvate脱酶激酶4 (PDK4) 可能治疗新血管与年龄相关的黄斑变性 (AMD). 在视网膜细胞中抑制PDK4可恢复线粒体功能并减少炎症,为AMD提供了新的治疗策略.